Literature DB >> 15599880

Rapidly progressive glomerulonephritis: current and evolving treatment strategies.

Mark A Little1, Charles D Pusey.   

Abstract

Rapidly progressive glomerulonephritis (RPGN) must be diagnosed and treated quickly to prevent irreversible organ injury. The commonest cause of RPGN is anti-neutrophil cytoplasm antibody (ANCA) associated small vessel vasculitis, and the most severe is anti-glomerular basement membrane (GBM) antibody disease. In this review we address pathogenesis, diagnosis, treatment and outcome in these two entities, with emphasis on novel therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599880

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  9 in total

1.  Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.

Authors:  L García; C E Pena; R Águila Maldonado; C Costi; M Mamberti; E Martins; M A García
Journal:  Clin Rheumatol       Date:  2019-06-20       Impact factor: 2.980

Review 2.  The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.

Authors:  Hui Bao; Ai Peng
Journal:  J Transl Int Med       Date:  2016-09-23

Review 3.  The role of plasmapheresis in critical illness.

Authors:  Trung C Nguyen; Joseph E Kiss; Jordana R Goldman; Joseph A Carcillo
Journal:  Crit Care Clin       Date:  2012-07       Impact factor: 3.598

Review 4.  The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease.

Authors:  Futoshi Matsui; Kirstan K Meldrum
Journal:  J Surg Res       Date:  2012-07-17       Impact factor: 2.192

5.  Immune-complex deposits in "pauci-immune" glomerulonephritis: a case report and brief review of recent literature.

Authors:  Mireille El-Ters; Umadevi Muthyala; Marie D Philipneri; Fadi A Hussein; Krista L Lentine
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

6.  Pulmonary-renal syndromes: Experience from an Indian Intensive Care Unit.

Authors:  Srinivas Rajagopala; Baburao Kanthamani Pramod Sagar; Molly Mary Thabah; B H Srinivas; Ramanathan Venkateswaran; Sreejith Parameswaran
Journal:  Indian J Crit Care Med       Date:  2015-06

7.  Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation.

Authors:  Yajuan Li; Mei Yan; Jichen Yang; Indu Raman; Yong Du; Soyoun Min; Xiangdong Fang; Chandra Mohan; Quan-Zhen Li
Journal:  Stem Cell Res Ther       Date:  2014-01-30       Impact factor: 6.832

Review 8.  Rapidly progressive glomerulonephritis in children.

Authors:  Khemchand N Moorani; Madiha Aziz; Farhana Amanullah
Journal:  Pak J Med Sci       Date:  2022-01       Impact factor: 1.088

9.  Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report.

Authors:  Christoph Preul; Jens Gerth; Sebastian Lang; Christoph Bergmeier; Otto W Witte; Gunter Wolf; Christoph Terborg
Journal:  J Med Case Rep       Date:  2009-11-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.